Press Releases for ABT

Press Releases
Morgan Joseph Names Bruce D. Jackson a Senior Vice President in Equity Research Covering the Medical Device Industry
PanGenetics Announces Acquisition by Abbott of PG110 anti-NGF Antibody to Treat Chronic Pain
Impax Laboratories Confirms Patent Challenge Relating to TRICOR® 48mg and 145mg Tablets
Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual Property Portfolio
UPI NewsTrack Business
Wall Street mergers show return of chutzpah
Abbott to Collaborate With Pfizer Inc on Companion Diagnostic Test to Select Patient Candidates for Novel Investigational Non-Small Cell Lung Cancer Therapy
Medtronic Reports First Quarter Revenue of $3.9 Billion
Health Canada Approves Abbott's XIENCE V(R) Drug Eluting Stent
Abbott Announces Partnership with Velcera to Bring New Pain Medication for Dogs to Market
StreetSmart Strategies®, a Management Consulting Firm, Retains Veteran Corporate Investor Relations Officer David Prichard
Abbott Expands XIENCE V(R) USA Trial to Enroll Patients into Landmark Dual Anti-Platelet Therapy (DAPT) Trial
Impax Laboratories Receives Final FDA Approval for Generic Depakote® Extended-Release 500mg Tablets
Absolute Refutes Claims of BIOS Vulnerability
Abbott Testifies Before U.S. Congress on Role of Private Sector in Advancing Science Education
Abbott to Acquire Nutrition Businesses, Expanding Presence in India
Abbott and Medtronic Reach Agreement on Global Patent Disputes
Accuray Announces CyberKnife Access Remote Service Product ; Purchase of Axeda ServiceLink Solution Enables Fast and Effective Servicing
NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test
New Diagnostic Biomarker Test Shows Promise in Monitoring Ovarian Cancer
Investigational Urine NGAL Biomarker Shows Promise to Monitor Cyclosporine Toxicity in Cardiac Transplant Patients
Abbott HIV Test Demonstrates Earlier Disease Detection
Absolute Software to Host Conference Call for Fiscal 2009 Year-End and Fourth Quarter Financial Results
Labs Are Vital(TM) Announces Winners of 2009 National Video Contest to Highlight Careers in Lab Sciences
Abbott Introduces Molecular Diagnostic System Intended for Broad Identification of Infectious Agents
Abbott Launches New Instrument to Complete Family of ARCHITECT Immunochemistry Analyzers
Absolute Software Announces Successful Laptop Recovery for Austin Area Schools
Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009
Health Discovery Corporation Announces Publication of Peer Reviewed Scientific Paper Demonstrating the Clinical Validity of the Four-Gene Prostate Cancer Test Licensed to Abbott, Quest Diagnostics and Clarient
Abbott and GSK to Collaborate on Molecular Diagnostic Test to Select Candidate Patients for Future Cancer Immunotherapy
Abbott and Oasmia Pharmaceutical Announce Exclusive Distribution Agreement for Paccal(R) Vet, a New Chemotherapeutic Agent for Dogs
Absolute Software Announces Support for Windows 7
OneChicago Reports June Volume
InvestorSoup.com Researches: Oracle, Comcast, Cytori, Wal-Mart, Abbot and GT Solar
UPI NewsTrack Business
Abbott ordered to pay $1.7B patent claim
Absolute Helps Police Break Possible Identity Theft Ring
Absolute's Computrace Included in a Major Computer Manufacturer's Customer Care Program
Abbott Hosts Conference Call for Second-Quarter Earnings
Absolute Launches Computrace LoJack for Laptops in Europe
Select Acer Computers to Ship With Absolute's Computrace and Intel(R) Anti-Theft Technology
Abbott Receives CE Mark for Company's Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Advancing Leadership Position
MERCEDES-BENZ Launches All-New 2010 E-Class: 'Everything We Know, Everything We Are: This is Mercedes-Benz'
Schmidt & Clark, LLP: FDA Reports Show Abbott Labs Subsidiary Failed to Disclose Parasite Eye Infections Tied to Contact Lens Solution
SAFE-BioPharma Changes Fees to Help Clinical Investigators, CROs, Others
S&P 500 Stock Buybacks Retreat 73% in the First Quarter; Lowest Since Second Quarter of 2003
June 23 DIA Sessions Chaired By SAFE-BioPharma Association
Abbott Initiates Trial of Next-Generation XIENCE PRIME(TM) Drug Eluting Stent, Building Upon Superior Outcomes from SPIRIT Family of Trials
RTS Bolsters Sales Staff at Corporate Headquarters With Addition of John Berschied As National Account Manager/Engineer
Abbott Declares 342nd Consecutive Quarterly Dividend
Abbott Announces Launch of Next-Generation Embolic Protection System
Abbott Announces New EAS(R) Myoplex(R) Strength Formula Nutrition Shake and Debuts Bottle Packaging
DiagnoCure Announces Second Quarter Financial Results
Abbott's TRILIPIX(R) (Fenofibric Acid) in Combination With Rosuvastatin Calcium Helps Patients With Mixed Dyslipidemia and Type 2 Diabetes Meet American Diabetes Association Lipid Targets
Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of TRILIPIX(R) (fenofibric acid)
Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia
Three New ZonePerfect(R) Dark Chocolate Nutrition Bar Flavors Fuel Satisfying and Delicious Snacking
Abbott to Present at Goldman Sachs Global Healthcare Conference
Abbott Named One of the Top 10 Companies for Scientists
Report: IBM Ranked #1 in Web Portal Software Market Share
Accelrys Announces Fourth Quarter and Full Year Fiscal 2009 Financial Results
Abbott's XIENCE V(R) Demonstrates Impressive Low Rates of Repeat Procedure, Stent Thrombosis and Major Adverse Cardiac Events in Complex, 'Real World' Patients in SPIRIT V Study
Abbott Announces EuroPCR 2009 Activities
Flowserve Holds 2009 Annual Meeting of Shareholders
Follica Appoints Drug Development and Dermatology Veteran, William D. Ju, As Chief Executive Officer
MaybachFinancial.Com Posts Free Analyst Report on ABT, AEP, CAT and CVC
HIV/AIDS Research Network Recommends Use of Abbott RealTime Viral Load Test for NIH-Sponsored Clinical Trials
Abbott Highlights Strong Corporate Responsibility Performance With Release of 2008 Global Citizenship Report
Abbott Annual Meeting Highlights Outstanding 2008 Results, Continued Strong Outlook
PDI Appoints David E. Kerr Senior Vice President of Business Development
Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009 - Apr 15 2009 10:55AM
Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009 - Apr 15 2009 7:51AM
Beacon Equity Issues Trade Alerts on Medical Device Stocks: ABT, BSX, JNJ, BAX, HSP, ZMH
Absolute and McAfee Partner to Offer Consumers Absolute's Computrace LoJack for Laptops
Zacks Analyst Blog Highlights: Pfizer Inc., Wyeth, Satyam Computer Services Ltd., Abbott Laboratories and Boston Scientific Inc.
Catch the Rising Stars of Medical Technology in Paris, France, at the Upcoming Investment-In-Innovation (In3) Europe Conference, April 29-30, 2009, Paris, France
Zacks Industry Outlook Highlights: Bristol-Myers, Johnson &Amp; Johnson and Abbott Labs
Research and Markets: Menarini Group - The Complete Strategic Analysis Review of This Biopharmaceutical Company
American Recovery and Reinvestment Act (ARRA) Provides Financial Incentives to Migrate Medical Files to Digital Formats, Opening Doors to New Security and Privacy Risks for Healthcare Institutions
Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
Computrace by Absolute Software Now Supported in Firmware of Getac Computers
Zacks Bull &Amp; Bear of the Day Highlights: Johnson &Amp; Johnson, BJ Services, Saks, Wal-Mart and LeapFrog Enterprises
Schaeffer's Street Stories: Options Players Have Doubts About Abbott Laboratories Ahead of Earnings
New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management
Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years
BetterInvesting Magazine Releases June's Stock to Study and Undervalued Stock Choices For Investors' Informational and Educational Use - Mar 27 2009 7:19PM
Abbott Hosts Conference Call for First-Quarter Earnings - Mar 25 2009 10:30AM
Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial
Absolute Launches New Global Customer Center With Enhanced Security and Management Features
Absolute Software Announces Automatic Share Purchase Plan - Mar 23 2009 5:17PM
Photo: ZonePerfect(R) Nutrition Bars Launches Nationwide Tour With VH1 Save The Music Foundation to Nourish Arts, America's Schools
Together Rx Access(R) Program Expands Eligibility Criteria, Responds to Challenging Economic Times
Zacks Bull & Bear of the Day Highlights: Boston Scientific, Patriot Capital, AIG, Citigroup and Morgan Stanley - Mar 18 2009 11:51PM
Zacks Bull & Bear of the Day Highlights: Boston Scientific, Patriot Capital, AIG, Citigroup and Morgan Stanley - Mar 18 2009 7:17AM
Zacks Analyst Blog Highlights: CNOOC Ltd., The Coca-Cola Company, Boston Scientific Corp., Abbott Laboratories and Sanmina-SCI
Research and Markets: Keep Abreast of Spain's Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015
Research and Markets: China Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2015 Out Now
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter
Catch the Rising Stars of Medical Technology in Paris, France at the Upcoming Investment-In-Innovation (In3) Europe Conference - Mar 9 2009 11:54PM